US › Healthcare

Nuwellis Inc (NUWE)

US · Healthcare · Medical Devices

$1.09+33.74%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$2.0M

Revenue YoY

+14.1%

Net profit

$-4.8M

EPS

$-26.64

EPS estimate

$-23.80

Net margin

-245.2%

EPS came in at -26.64 against a street estimate of -23.80 — a miss of 11.9%.

Key statistics

Market cap

$2.6M

P/E

0.0

Forward P/E

0.0

P/B

0.18

Book value

$-3.58

EPS (TTM)

$2,548.34

52-week high

$172.90

52-week low

$0.71

50-day MA

$1.73

200-day MA

$39.02

Beta

0.23

Analyst view

Analysts rate Nuwellis Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $11.00.

Shareholding

Insiders

6.12%

Institutions

2.59%

Largest institutional holders

Fund	Stake
Armistice Capital, LLC	1.85%
Geode Capital Management, LLC	0.35%
Tower Research Capital LLC	0.04%
Citigroup Inc	0.04%
SBI Securities Co Ltd	0.00%
UBS Group AG	0.00%
Caitong International Asset Management Co., Limited.	0.00%
Ankerstar Wealth, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Nuwellis Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.